Atopic Dermatitis
Latest News
Roflumilast foam effectively eases seborrheic dermatitis
The study evaluated a foam formulation of roflumilast, a PDE4 inhibitor that is available for topical use in a cream formulation that was recently...
Latest News
Dupilumab offers ‘clinically meaningful’ improvements in prurigo nodularis
Although various treatments are used off label for many patients with moderate to severe PN, disease control is inadequate, and the patients are “...
Contact Dermatitis
Can Atopic Dermatitis and Allergic Contact Dermatitis Coexist?
Although it previously was thought that atopic dermatitis (AD) and allergic contact dermatitis (ACD) could not coexist due to their polarized...
Latest News
VTE risk not elevated in AD patients on JAK inhibitors: Study
The labels of JAK inhibitors include a boxed warning describing an increased risk of “serious heart-related events such as heart attack or stroke...
From the Journals
Abrocitinib evaluated in patients with and without prior dupilumab treatment
“These results ... support the use of abrocitinib in patients who might have received biologic therapy prior.”
Latest News
Why it’s important for dermatologists to learn about JAK inhibitors
“We are going to be getting a lot more indications for these drugs,” Dr. Andrew Blauvelt said.
Case Letter
Intralesional Human Papillomavirus Vaccine Therapy for Recalcitrant Plantar Wart Triggers Gout Flare
There is increasing evidence supporting the use of the human papillomavirus (HPV) vaccine in the treatment of recalcitrant common warts.
Latest News
Vitamin D supplements during pregnancy may protect infants from atopic eczema
“Our data provide the first randomized controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on risk of...
Conference Coverage
Topical ruxolitinib quickly relieves atopic dermatitis itch in Black patients
Ruxolitinib cream provides quick itch relief for Black patients with atopic dermatitis, researchers report.
Conference Coverage
Cultural humility required to optimize treatment of eczema patients with skin of color
Treating eczema in patients with skin of color requires cultural lens.
The Optimized Doctor
‘I shall harm’
Nocebo, from the Latin “I shall harm,” is the dark counterpart to the placebo.